SCHEMBL363388

SCHEMBL363388

Cc1cc(C(=O)Cc2ccccc2)cc(C)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM1 Q13255 1/20 0.57
MAPT P10636 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
SRD5A2 P31213 2/20 0.50
PLAU P00749 1/20 0.50
RAB9A P51151 4/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
GALR3 O60755 1/20 0.49
HTT P42858 1/20 0.49
GAA P10253 1/20 0.49
PDCD1 Q15116 1/20 0.48
CD274 Q9NZQ7 1/20 0.48
LMNA P02545 1/20 0.47
KDM4E B2RXH2 2/20 0.47
NPC1 O15118 2/20 0.47
ALDH1A1 P00352 1/20 0.47
KMT2A Q03164 1/20 0.47
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
AKR1B1 P15121 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL839299 0.81 GRM1 (0.50) GRM1MAPTL3MBTL1SRD5A2PLAU
SCHEMBL28057812 0.80 RAB9A (0.50) GRM1L3MBTL1RAB9ASMN1; SMN2GALR3
SCHEMBL8521721 0.79 MAPT (0.51) GRM1MAPTL3MBTL1SRD5A2PLAU
Methyl Alcohol SCHEMBL11602292 0.77 MAPT (0.68) MAPTL3MBTL1SRD5A2PLAURAB9A
SCHEMBL3890832 0.76 TPMT (0.42) GRM1L3MBTL1RAB9ASMN1; SMN2HTT
SCHEMBL7129800 0.76 MAPT (0.80) MAPTL3MBTL1SRD5A2PLAURAB9A
SCHEMBL24800 0.76 MAPT (0.73) MAPTL3MBTL1SRD5A2PLAURAB9A
SCHEMBL1390105 0.76 HDAC6 (0.43) MAPTL3MBTL1RAB9ASMN1; SMN2HTT
SCHEMBL14524129 0.76 LMNA (0.56) GRM1MAPTL3MBTL1SRD5A2PLAU
SCHEMBL1515693 0.76 L3MBTL1 (0.68) MAPTL3MBTL1SRD5A2RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GRM1 74/4885MAPT 4149/4885L3MBTL1 2596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.